Tag: Vaccines
COVID-19 Vaccination Greatly Reduced Morbidity, Mortality Burden in U.S.
Vaccination estimated to have prevented 52, 56, and 58 percent of expected infections, hospitalizations, deaths in adults from Sept. 1 to 30, 2021
Provider Availability Linked to COVID-19 Vaccine Uptake in Children
Vaccination coverage for children aged 5 to 11 higher in counties with at least one active COVID-19 vaccine provider versus no provider
Vaccination Protects Overweight, Obese Against Severe COVID-19
Protection against severe COVID-19 similar for those with overweight, obesity versus healthy weight; lower protection seen for underweight
FDA Tells Vaccine Makers to Update Boosters to Target Omicron Subvariants
Pfizer and Moderna are expected to start producing reformulated doses this summer
U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
Both Pfizer and Moderna have reported positive results with updated vaccines that target the omicron variant
Two Doses of BNT162b2 Moderately Effective for 5- to 11-Year-Olds
Moderate effectiveness against documented infection and symptomatic COVID-19 for those vaccinated on or after Nov. 23, 2021
ACIP Recommends COVID-19 Vaccines for Children Aged ≥6 Months
ACIP interim recommendations presented for Moderna, Pfizer-BioNTech mRNA vaccines for children aged 6 months to 5 years
U.S. Begins Targeted Vaccine Rollout Against Monkeypox
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine
FDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
Advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations
Vaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
More deaths would have been averted had vaccine coverage targets from COVAX and WHO been met